Iontophoresis of lithium antagonizes noradrenergic action on prefrontal neurons of the rat.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain Research

• Publication date

  2002-08-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-8993(02)03150-5PMID 12144864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral noradrenergic function during chronic lithium treatment in the rat

  2005cited by this paper
• The effect of short-term lithium administration on noradrenaline metabolism in the limbic forebrain and hemispheres of rats

  2005cited by this paper
• A common mechanism of action for three mood-stabilizing drugs

  2002cited by this paper
• An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation.

  2001cited by this paper
• Noradrenaline modulates GABA-mediated synaptic transmission in neurones of the mediolateral part of the guinea pig lateral septum via local circuits.

  2001cited by this paper
• The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis.

  2001cited by this paper
• Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli

  2000cited by this paper
• Alterations of conditioned taste aversion after microiontophoretically applied neurotoxins in the medial prefrontal cortex of the rat.

  2000cited by this paper
• α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function

  1999cited by this paper
• The neuropathological effects of antipsychotic drugs.

  1999cited by this paper
• Differential Coupling of α1-, α2-, and β-Adrenergic Receptors to Mitogen-activated Protein Kinase Pathways and Differentiation in Transfected PC12 Cells*

  1998cited by this paper
• Lithium and psychosis revisited.

  1998cited by this paper
• Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells.

  1998cited by this paper
• Therapeutic Drug Monitoring and Clinical Biochemistry

  1997cited by this paper
• Effects of Chronic Lithium Treatment on Agonist‐Enhanced Extracellular Concentrations of Cyclic AMP in the Dorsal Hippocampus of Freely Moving Rats

  1995cited by this paper
• The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects.

  1991cited by this paper
• Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study.

  1991cited by this paper
• Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions

  1989cited by this paper
• Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex

  1988cited by this paper
• Acute effects of lithium chloride on noradrenergic neurons from rat cerebral cortex.

  1984cited by this paper
• The History of Lithium Therapy

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Lithium elimination half‐life and duration of therapy

  1981cited by this paper
• Iontophoresis of Li+ antagonizes noradrenergic synaptic inhibition of rat cerebellar Purkinje cells.

  1979cited by this paper
• Biogenic amines and affective disorders.

  1974cited by this paper
• Lithium and the monoamine neurotransmitters in the rat hippocampus

  1974cited by this paper
• Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

  1973cited by this paper

• Lithium engages autophagy for neuroprotection and neuroplasticity: translational evidence for therapy.

  2023cites this paper
• Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview

  2021cites this paper
• PATHOPHYSIOLOGY OF MOOD DISORDERS: NORADRENERGIC MECHANISMS

  2013cites this paper
• ROLE OF LOCUS COERULEUS AND AMYGDALA PROJECTIONS TO VENTRAL SUBICULUM IN STRESS REGULATION

  2011cites this paper
• Brain norepinephrine system as a target for antidepressant and mood stabilizing medications.

  2009cites this paper
• Noradrenergic Modulation of Basolateral Amygdala Neuronal Activity: Opposing Influences of α-2 and β Receptor Activation

  2007cites this paper
• Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation.

  2007cites this paper
• Noradrenergic Modulation of the Basolateral Amygdala: Alterations by Stress Exposure

  2007cites this paper
• Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.

  2006cites this paper
• Interaction of lithium with neurotransmitter systems: serotonin and others

  2006cites this paper
• Microiontophoresis electrode location by neurohistological marking: Comparison of four native dyes applied from current balancing electrode channels.

  2005cites this paper
• Effect of lithium on norepinephrine metabolic pathways.

  2005cites this paper
• Molecular targets of lithium action

  2003cites this paper